X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8131) 8131
Newsletter (37) 37
Magazine Article (34) 34
Newspaper Article (9) 9
Publication (8) 8
Book Chapter (6) 6
Dissertation (4) 4
Book / eBook (2) 2
Transcript (2) 2
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6960) 6960
male (4468) 4468
omeprazole (4267) 4267
female (4077) 4077
omeprazole - therapeutic use (4003) 4003
middle aged (3352) 3352
adult (3019) 3019
gastroenterology & hepatology (2870) 2870
anti-ulcer agents - therapeutic use (2859) 2859
proton pump inhibitors (2289) 2289
aged (2279) 2279
pharmacology & pharmacy (2109) 2109
helicobacter infections - drug therapy (1907) 1907
treatment outcome (1603) 1603
helicobacter pylori (1595) 1595
lansoprazole (1467) 1467
drug therapy, combination (1450) 1450
2-pyridinylmethylsulfinylbenzimidazoles (1347) 1347
omeprazole - analogs & derivatives (1278) 1278
gastroesophageal reflux - drug therapy (1233) 1233
omeprazole - administration & dosage (1099) 1099
anti-bacterial agents - therapeutic use (1002) 1002
amoxicillin - therapeutic use (892) 892
therapy (843) 843
adolescent (833) 833
prospective studies (816) 816
proton pump inhibitors - therapeutic use (793) 793
anti-ulcer agents - administration & dosage (784) 784
double-blind method (777) 777
clarithromycin - therapeutic use (776) 776
infection (756) 756
ranitidine (726) 726
animals (716) 716
duodenal ulcer - drug therapy (713) 713
omeprazole - adverse effects (691) 691
aged, 80 and over (685) 685
time factors (669) 669
helicobacter pylori - drug effects (656) 656
gastroesophageal reflux (651) 651
histamine h2 antagonists - therapeutic use (642) 642
omeprazole - pharmacology (611) 611
peptic ulcer - drug therapy (611) 611
eradication (607) 607
hydrogen-ion concentration (598) 598
medicine, general & internal (580) 580
rabeprazole (580) 580
enzyme inhibitors - therapeutic use (573) 573
double-blind (568) 568
proton pump inhibitor (566) 566
ranitidine - therapeutic use (565) 565
recurrence (546) 546
benzimidazoles - therapeutic use (529) 529
helicobacter infections - complications (526) 526
drug interactions (525) 525
stomach ulcer - drug therapy (523) 523
disease (521) 521
amoxicillin (515) 515
pantoprazole (509) 509
duodenal-ulcer (499) 499
follow-up studies (497) 497
risk factors (496) 496
pharmacokinetics (494) 494
efficacy (481) 481
metronidazole - therapeutic use (476) 476
medicine & public health (475) 475
drug administration schedule (474) 474
gastroesophageal reflux - complications (469) 469
clarithromycin (467) 467
dose-response relationship, drug (466) 466
management (446) 446
anti-ulcer agents - adverse effects (444) 444
gastroesophageal reflux disease (433) 433
esophagitis (430) 430
esomeprazole (427) 427
esophagitis, peptic - drug therapy (416) 416
care and treatment (410) 410
helicobacter infections - microbiology (392) 392
triple therapy (390) 390
helicobacter pylori - isolation & purification (387) 387
rats (384) 384
gastric acid - secretion (377) 377
risk (376) 376
anti-ulcer agents - pharmacology (374) 374
gastroesophageal-reflux disease (374) 374
prevalence (371) 371
young adult (369) 369
proton pump inhibitors - adverse effects (368) 368
administration, oral (366) 366
metronidazole (348) 348
symptoms (342) 342
gastroesophageal reflux - diagnosis (336) 336
gastric acid - metabolism (332) 332
gastroenterology (330) 330
drug therapy (329) 329
anti-inflammatory agents, non-steroidal - adverse effects (327) 327
endoscopy (316) 316
child (310) 310
ulcers (310) 310
omeprazole - pharmacokinetics (306) 306
cross-over studies (303) 303
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7527) 7527
Spanish (148) 148
Japanese (138) 138
German (132) 132
Russian (132) 132
French (120) 120
Chinese (32) 32
Italian (27) 27
Dutch (14) 14
Polish (13) 13
Korean (10) 10
Hungarian (8) 8
Danish (7) 7
Portuguese (7) 7
Swedish (7) 7
Ukrainian (7) 7
Czech (3) 3
Finnish (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Romanian (2) 2
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 10, pp. 931 - 932
Internal Medicine | MEDICINE, GENERAL & INTERNAL | STEVENS-JOHNSON-SYNDROME | Acetaminophen - adverse effects | Dacarbazine - adverse effects | Methylprednisolone - therapeutic use | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - therapeutic use | Wound Healing | Anticonvulsants - adverse effects | Piracetam - therapeutic use | Stevens-Johnson Syndrome - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Antiemetics - adverse effects | Oxycodone - therapeutic use | Stevens-Johnson Syndrome - etiology | Anticonvulsants - therapeutic use | gamma-Globulins - therapeutic use | Analgesics, Opioid - therapeutic use | Stevens-Johnson Syndrome - diagnosis | Dexamethasone - therapeutic use | Glioblastoma - pathology | Piracetam - analogs & derivatives | Glioblastoma - complications | Glioblastoma - drug therapy | gamma-Globulins - administration & dosage | Dacarbazine - therapeutic use | Piracetam - adverse effects | Erythema - chemically induced | Analgesics, Opioid - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Erythema - diagnosis | Dacarbazine - analogs & derivatives | Oxycodone - adverse effects | Acetaminophen - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Immunologic Factors - administration & dosage | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Drug Combinations | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Medicine, Experimental | Toxic epidermal necrolysis | Medical research | Research
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 11/2011, Volume 106, Issue 11, pp. 1970 - 1975
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 33 - 35
.... Its use poses higher risks of lymphopenia and opportunistic infections. Prophylaxis for Pneumocystis... 
Oncology | Opportunistic infections | Temozolomide | Medicine & Public Health | Lymphopenia | ONCOLOGY | RISK | RADIOTHERAPY | ANEMIA | PURE | RED-CELL APLASIA | CLINICAL NEUROLOGY | Dacarbazine - adverse effects | Red-Cell Aplasia, Pure - drug therapy | Heptanoic Acids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - chemically induced | Dacarbazine - analogs & derivatives | Anti-Inflammatory Agents - therapeutic use | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Fluoxetine - therapeutic use | Pyrroles - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Anti-Infective Agents - therapeutic use | Anticonvulsants - therapeutic use | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Brain Neoplasms - drug therapy | Radiotherapy | Pyrazinamide - therapeutic use | Atorvastatin Calcium | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Phenobarbital - therapeutic use | Anticholesteremic Agents - therapeutic use | Antibiotics, Antitubercular - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Prednisone - therapeutic use | Online health care information services | Pneumonia | Tuberculosis | Gliomas | Analysis | Bacterial pneumonia | Brain tumors | Pyrazinamide | Health aspects | Rifampin | Index Medicus
Journal Article
The American journal of gastroenterology, ISSN 1572-0241, 2006, Volume 101, Issue 2, pp. 243 - 247
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2009, Volume 101, Issue 4, pp. 714 - 719
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9694, pp. 989 - 997
.... Conflicting data exist as to whether PPIs diminish the efficacy of clopidogrel. We assessed the association between PPI use, measures of platelet function, and clinical outcomes for patients treated with clopidogrel or prasugrel... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | PLATELET-AGGREGATION | OF-FUNCTION POLYMORPHISM | OMEPRAZOLE | THROMBOLYSIS | ACUTE CORONARY SYNDROMES | OUTCOMES | ANTIPLATELET ACTION | ATORVASTATIN | Multivariate Analysis | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Pyridines - adverse effects | Drug Interactions | Ticlopidine - adverse effects | Cardiovascular Diseases - epidemiology | Female | Platelet Aggregation - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Proton Pump Inhibitors - adverse effects | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Piperazines - therapeutic use | Proton Pump Inhibitors - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Acute Coronary Syndrome - drug therapy | Aged | Complications and side effects | Clopidogrel | Proton pump inhibitors | Dosage and administration | Pharmacology | Research | Properties | Studies | Data collection | Data analysis | Drug therapy | Acute coronary syndromes | Clinical outcomes | Cytochrome | Myocardial infarction | Cerebral infarction | Stroke | Funding | Clinical trials | Platelet aggregation | Agglomeration | Patients | Evidence-based medicine | Randomization | Blood platelets | Infarction | Inhibition | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 20, pp. 1909 - 1917
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2001, Volume 344, Issue 13, pp. 967 - 973
Journal Article
Gut, ISSN 0017-5749, 06/2012, Volume 61, Issue 6, pp. 812 - 818
... in the foreseeable future? This study suggests that a single anti-H pylori treatment or long-term use of celecoxib has a favourable effect on the regression of H pylori... 
NONSTEROIDAL ANTIINFLAMMATORY DRUGS | HIGH-RISK | DOUBLE-BLIND | RANDOMIZED-TRIAL | CHEMOPREVENTION | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-PRACTICE | CANCER | CELECOXIB | CYCLOOXYGENASE-2 INHIBITOR | CHINESE POPULATION | Precancerous Conditions - etiology | Pyrazoles - therapeutic use | Humans | Middle Aged | Helicobacter Infections - complications | Male | Stomach Neoplasms - pathology | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Helicobacter Infections - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Clarithromycin - administration & dosage | Adult | Female | Precancerous Conditions - pathology | Amoxicillin - administration & dosage | Drug Therapy, Combination | Stomach Neoplasms - etiology | Omeprazole - therapeutic use | Stomach - pathology | Double-Blind Method | Omeprazole - administration & dosage | Clarithromycin - therapeutic use | Celecoxib | Sulfonamides - therapeutic use | Stomach Neoplasms - prevention & control | Amoxicillin - therapeutic use | Precancerous Conditions - prevention & control | Anti-Bacterial Agents - administration & dosage | COX-2 inhibitors | Helicobacter infections | Dosage and administration | Research | Drug therapy | Precancerous conditions | Studies | Pathology | Antibiotics | Biopsy | Quality | Population | Endoscopy | Stomach cancer | Index Medicus | Abridged Index Medicus
Journal Article